Advertisement

Pediatric Cardiology

, Volume 34, Issue 5, pp 1088–1093 | Cite as

Effects of Circuit Residual Volume Salvage Reinfusion on the Postoperative Clinical Outcome for Pediatric Patients Undergoing Cardiac Surgery

  • LiFen Ye
  • Ru Lin
  • Yong Fan
  • LiJun Yang
  • JianLing Hu
  • Qiang ShuEmail author
Original Article

Abstract

This study aimed to evaluate the effects of washed cardiopulmonary (CPB) circuit residual blood reinfusion on the postoperative clinical outcome for pediatric patients undergoing cardiac surgery. A total of 309 consecutive Chinese cardiac patients receiving CPB between October 2010 and April 2011 were prospectively analyzed. For 217 patients, CPB circuit residual blood was reinfused after the cell-saving procedure [cell-salvage group (CS)]. The remaining 92 patients were directly transfused with allogenic red blood cells (RBCs) after their operation [control group (CON)]. Assessment included perioperative transfusion of RBCs, postoperative hematocrit (HCT), chest tube drainage during the first 24 h after the operation, intrahospital mortality, respiratory morbidity, and renal dysfunction. The two groups were well matched in terms of demographics, CPB data, and complexity of surgical procedure. The patients in the CS group had a significantly higher HCT level postoperatively (p = 0.018) and a less allogenic RBCs transfusion (p = 0.000). The two groups did not differ in terms of chest tube drainage during the first 24 h postoperatively, intrahospital mortality, or respiratory morbidity. The incidence of serum creatinine (≥2-folds) during the first 72 h after the operation was significantly lower in the CS group (2.3 %) than in the CON group (8.7 %) (p = 0.010). Reinfusion of washed CPB circuit residual blood significantly raised the postoperative HCT level, reduced the allogeneic blood transfusion, decreased the incidence of early postoperative renal dysfunction, and did not increase the chest tube drainage after the operation in pediatric cardiac surgery.

Keywords

Cardiopulmonary bypass Cell salvage Clinical outcome Pediatric cardiac surgery 

Notes

Acknowledgments

This work was financially supported by the National Science and Technology Foundation of China (2012BAI04B05), the Zhejiang Province innovation team for early screening and intervention of birth defects (2010R50045), the Health Bureau of Zhejiang Provincial Key Program (2012ZDA030; 2012ZDA031), and the Fundamental Research Funds for the Central Universities, Ministry of Education (2011KYJD008; 2012QNA7041).

References

  1. 1.
    Campbell J, Holland C, Richens D, Skinner H (2012) Impact of cell salvage during cardiac surgery on the thrombelastomeric coagulation profile: a pilot study. Perfusion 27:221–224PubMedCrossRefGoogle Scholar
  2. 2.
    Daane CR, Golab HD, Meeder JH, Wijers MJ, Bogers AJ (2003) Processing and transfusion of residual cardiopulmonary bypass volume: effects on haemostasis, complement activation, postoperative blood loss, and transfusion volume. Perfusion 18:115–121PubMedCrossRefGoogle Scholar
  3. 3.
    Djaiani G, Fedorko L, Borger MA, Green R, Carroll J, Marcon M, Karski J (2007) Continuous-flow cell saver reduces cognitive decline in elderly patients after coronary bypass surgery. Circulation 116:1888–1895PubMedCrossRefGoogle Scholar
  4. 4.
    Dorneles Cde C, Bodanese LC, Guaragna JC, Macagnan FE, Coelho JC, Borges AP, Goldani MA, Petracco JB (2011) The impact of blood transfusion on morbidity and mortality after cardiac surgery. Rev Bras Cir Cardiovasc 26:222–229PubMedCrossRefGoogle Scholar
  5. 5.
    Durandy Y (2007) Usefulness of low prime perfusion pediatric circuit in decreasing blood transfusion. ASAIO J 53:659–661PubMedCrossRefGoogle Scholar
  6. 6.
    Ferraris VA, Ferraris SP (1995) Limiting excessive postoperative blood transfusion after cardiac procedures. Tex Heart Inst J 22:216–230PubMedGoogle Scholar
  7. 7.
    Goel P, Pannu H, Mohan D, Arora R (2007) Efficacy of cell saver in reducing homologous blood transfusions during OPCAB surgery: a prospective randomized trial. Transfus Med 17:285–289PubMedCrossRefGoogle Scholar
  8. 8.
    Golab HD, Takkenberg JJ, van Gerner-Weelink GL, Wijers MJ, Scohy TV, de Jong PL, Bogers AJ (2007) Effects of cardiopulmonary bypass circuit reduction and residual volume salvage on allogeneic transfusion requirements in infants undergoing cardiac surgery. Interact Cardiovasc Thorac Surg 6:335–339PubMedCrossRefGoogle Scholar
  9. 9.
    Henrick B, Keartland P, McCarthy A, Daly L, Wood AE (1998) Residual blood in neonatal oxygenators after drainage. J Extra Corpor Technol 30:190–192PubMedGoogle Scholar
  10. 10.
    Koch CG, Li L, Duncan AI, Mihaljevic T, Cosgrove DM, Loop FD, Starr NJ, Blackstone EH (2006) Morbidity and mortality risk associated with red blood cell and blood component transfusion in isolated coronary artery bypass grafting. Crit Care Med 34:1608–1616PubMedCrossRefGoogle Scholar
  11. 11.
    Koch C, Li L, Figueroa P, Mihaljevic T, Svensson L, Blackstone EH (2009) Transfusion and pulmonary morbidity after cardiac surgery. Ann Thorac Surg 88:1410–1418PubMedCrossRefGoogle Scholar
  12. 12.
    Lacour-Gayet F, Clarke D, Jacobs J, Comas J, Daebritz S, Daenen W, Gaynor W et al (2004) The Aristotle score: a complexity-adjusted method to evaluate surgical results. Eur J Cardiothorac Surg 25:911–924PubMedCrossRefGoogle Scholar
  13. 13.
    McGill N, O’Shaughnessy D, Pickering R, Herbertson M, Gill R (2002) Mechanical methods of reducing blood transfusion in cardiac surgery: randomised controlled trial. BMJ 324:1299PubMedCrossRefGoogle Scholar
  14. 14.
    McKay C (2007) Perfusion approaches to blood conservation. Semin Cardiothorac Vasc Anesth 11:252–255PubMedCrossRefGoogle Scholar
  15. 15.
    Murphy GJ, Allen SM, Unsworth-White J, Lewis CT, Dalrymple-Hay MJ (2004) Safety and efficacy of perioperative cell salvage and autotransfusion after coronary artery bypass grafting: a randomized trial. Ann Thorac Surg 77:1553–1559PubMedCrossRefGoogle Scholar
  16. 16.
    Murphy GJ, Reeves BC, Rogers CA, Rizvi SI, Culliford L, Angelini GD (2007) Increased mortality, postoperative morbidity, and cost after red blood cell transfusion in patients having cardiac surgery. Circulation 116:2544–2552PubMedCrossRefGoogle Scholar
  17. 17.
    Niranjan G, Asimakopoulos G, Karagounis A, Cockerill G, Thompson M, Chandrasekaran V (2006) Effects of cell saver autologous blood transfusion on blood loss and homologous blood transfusion requirements in patients undergoing cardiac surgery on- versus off-cardiopulmonary bypass: a randomised trial. Eur J Cardiothorac Surg 30:271–277PubMedCrossRefGoogle Scholar
  18. 18.
    Nuis RJ, Van Mieghem NM, Tzikas A, Piazza N, Otten AM, Cheng J, van Domburg RT, Betjes M, Serruys PW, de Jaegere PP (2011) Frequency, determinants, and prognostic effects of acute kidney injury and red blood cell transfusion in patients undergoing transcatheter aortic valve implantation. Catheter Cardiovasc Interv 77:881–889PubMedCrossRefGoogle Scholar
  19. 19.
    Olshove VF Jr, Preston T, Gomez D, Phillips A, Galantowicz M (2010) Perfusion techniques toward bloodless pediatric open heart surgery. J Extra Corpor Technol 42:122–127PubMedGoogle Scholar
  20. 20.
    Rubens FD, Boodhwani M, Mesana T, Wozny D, Wells G, Nathan HJ, Cardiotomy Investigators (2007) The cardiotomy trial: a randomized, double-blind study to assess the effect of processing of shed blood during cardiopulmonary bypass on transfusion and neurocognitive function. Circulation 116(11 Suppl):I89–I97PubMedGoogle Scholar
  21. 21.
    Sandoval S, Alrawi S, Samee M, Satheesan R, Raju R, Cunningham JN, Acinapura AJ (2001) A cytokine analysis of the effect of cell saver on blood in coronary bypass surgery. Heart Surg Forum 4:113–117 discussion 117–119PubMedGoogle Scholar
  22. 22.
    Scott BH, Seifert FC, Grimson R (2008) Blood transfusion is associated with increased resource utilisation, morbidity, and mortality in cardiac surgery. Ann Card Anaesth 11:15–19PubMedCrossRefGoogle Scholar
  23. 23.
    Scrascia G, Rotunno C, Nanna D, Rociola R, Guida P, Rubino G, de Luca Tupputi Schinosa L, Paparella D (2012) Pump blood processing, salvage, and retransfusion improves hemoglobin levels after coronary artery bypass grafting, but affects coagulative and fibrinolytic systems. Perfusion 27:270–277PubMedCrossRefGoogle Scholar
  24. 24.
    Sirvinskas E, Lenkutis T, Raliene L, Veikutiene A, Vaskelyte J, Marchertiene I (2005) Influence of residual blood autotransfused from cardiopulmonary bypass circuit on clinical outcome after cardiac surgery. Perfusion 20:71–75PubMedCrossRefGoogle Scholar
  25. 25.
    Smigla GR, Lawson DS, Shearer IR, Jaggers J, Milano C, Welsby I (2004) An ultrafiltration technique for directly reinfusing residual cardiopulmonary bypass blood. J Extra Corpor Technol 36:231–234PubMedGoogle Scholar
  26. 26.
    Tyrrell CT, Bateman ST (2012) Critically ill children: to transfuse or not to transfuse packed red blood cells, that is the question. Pediatr Crit Care Med 13:204–209PubMedCrossRefGoogle Scholar
  27. 27.
    Venkataraman R, Kellum JA (2007) Defining acute renal failure: the RIFLE criteria. J Intensive Care Med 22:187–193PubMedCrossRefGoogle Scholar
  28. 28.
    Wang G, Bainbridge D, Martin J, Cheng D (2009) The efficacy of an intraoperative cell saver during cardiac surgery: a meta-analysis of randomized trials. Anesth Analg 109:320–330PubMedCrossRefGoogle Scholar
  29. 29.
    Willems A, Harrington K, Lacroix J, Biarent D, Joffe AR, Wensley D, Ducruet T, Hébert PC, Tucci M (2010) Comparison of two red-cell transfusion strategies after pediatric cardiac surgery: a subgroup analysis. Crit Care Med 38:649–656PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2012

Authors and Affiliations

  • LiFen Ye
    • 1
    • 3
  • Ru Lin
    • 1
    • 3
  • Yong Fan
    • 1
  • LiJun Yang
    • 1
  • JianLing Hu
    • 1
  • Qiang Shu
    • 1
    • 2
    Email author
  1. 1.Department of Thoracic and Cardiovascular SurgeryChildren’s Hospital, School of Medicine, Zhejiang UniversityHangzhouChina
  2. 2.Key Laboratory of Reproductive GeneticsZhejiang University, Ministry of EducationHangzhouChina
  3. 3.Key Laboratory for Diagnosis and Therapy of Neonatal DiseasesZhejiang UniversityHangzhouChina

Personalised recommendations